| Similar Articles |
|---|
 |
The Motley Fool
July 13, 2011 |
Immucor Earnings Preview After beating estimates last quarter by 5 cents, Immucor has set the standard for itself this Monday, July 18.   |
The Motley Fool
January 4, 2007
Rich Duprey |
Immucor Gets Blood Pumping Blood-testing diagnostic equipment maker beats estimates, but does so at a premium. Investors, take note. |
The Motley Fool
October 6, 2006
Brian Lawler |
No Bloodbath at Immucor The company appears right on track for double-digit revenue growth. Investors, it is worth watching to see how Immucor copes with the retirement of its CEO last month, but most likely everything should proceed as normal. |
The Motley Fool
January 4, 2007
Rich Duprey |
Pressure Rising at Immucor: Fool by Numbers The blood-testing company released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
April 5, 2007
Billy Fisher |
Another Boost for Immucor Since trading for pennies a share in 2001, shares of Immucor have been on a blistering pace. After the release of the company's third-quarter earnings recently, there's no apparent letup in sight, either. |
The Motley Fool
December 16, 2003
Alyce Lomax |
Immucor Bloodied The maker of instruments used by hospitals, labs, and blood banks for blood transfusions sees its shares battered after a second-quarter earnings warning. |
The Motley Fool
October 4, 2007
Billy Fisher |
Immucor Draws First Blood The blood-testing equipment maker sees double-digit growth in both sales and earnings in Q1. |
The Motley Fool
March 31, 2008
Rich Duprey |
Foolish Forecast: Immucor's Draining Acquisition In advance of earnings, analysts expect blood-tester Immucor to continue to grow sales and profits, in spite of short-term expenses. |
The Motley Fool
August 31, 2006 |
Foolish Fundamentals: Margins Margins are important, but how you use margin information is more important to your investing success. Don't stay on the surface when analyzing margins. Your portfolio will thank you for it later. |
The Motley Fool
August 17, 2005
David Meier |
The Power of Margins The way you think about margins can give you an investing edge. |
The Motley Fool
June 9, 2005
Richard Gibbons |
Buying on Margins Profit margins are one useful tool for finding great stock values. |
The Motley Fool
September 24, 2007
Billy Fisher |
Getting It Done at Meridian Bioscience Impressive earnings growth and disciplined spending continue to propel this small cap up and up. Investors, take note. |
The Motley Fool
November 6, 2007
Billy Fisher |
5 Health-Care Stocks: Bargain or Bust? They have strong earnings growth and are well off their 52-week highs. Is it time to buy these health care stocks?: WellCare Health Plans... Advanced Medical Optics... NBTY... Sciele Pharma... Immucor... |
The Motley Fool
January 6, 2011
Seth Jayson |
Should You Get Out of Immucor Before Next Quarter? Is Immucor sending any potential warning signs? Take a look at the chart below, which plots revenue growth against AR growth, and DSO. |
The Motley Fool
April 13, 2009
Rick Aristotle Munarriz |
3 Stocks That Blew the Market Away Take a look at three stocks that beat analysts' expectations: Bed Bath & Beyond... Immucor... Apogee Enterprises... |
